Friday, 21 March 2014

Simvastatin – a cholesterol lowering drug – might slow progression in people with secondary progressive MS.

Photo: This week, research confirmed that high doses of simvastatin – a cholesterol lowering drug – might slow progression in people with secondary progressive MS.

We caught up with the lead researcher on this trial, Dr Jeremy Chataway, who kindly agreed to tell us more about it and what the results could mean for people with progressive MS.

Read our interview here: http://bit.ly/1pewy31
Source MS Society:

This week, research confirmed that high doses of simvastatin – a cholesterol lowering drug – might slow progression in people with secondary progressive MS.

We caught up with the lead researcher on this trial, Dr Jeremy Chataway, who kindly agreed to tell us more about it and what the results could mean for people with progressive MS.  Click here.